Need professional-grade analysis? Visit stockanalysis.com
$48.67B
79.96
7,676
0.21%
Price Chart
Risk-Adjusted Performance
Galderma Group AG/ADR (GDERF) Price Performance
Galderma Group AG/ADR (GDERF) trades on United States in USD. The company is classified in the Healthcare sector under the Drug Manufacturers - Specialty & Generic industry. The stock currently trades at $204.70, up 2.22% from the previous close.
Over the past year, GDERF has traded between a low of $107.92 and a high of $208.90. The stock has gained 89.7% over this period. It is currently 89.7% above its 52-week low.
Galderma Group AG/ADR has a market capitalization of $48.67B, with a price-to-earnings ratio of 79.96 and a dividend yield of 0.21%.
About Galderma Group AG/ADR
Galderma Group AG operates as a dermatology company worldwide. The company delivers a science-based portfolio of brands and services for the dermatology market, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. Its portfolio of flagship brands includes Azzalure, ALLUZIENCE, Dysport, Restylane, Restylane Skinboosters, Sculptra, Cetaphil, ALASTIN, Soolantra, Epiduo, Epiduo Forte, Differin, AKLIEF, Oracea, Metvix, NEMLUVIO, Relfydess, Benzac, and Loceryl in therapeutic dermatology. The company was founded in 1981 and is headquartered in Zug, Switzerland.
Compare Galderma Group AG/ADR
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Exchange
- United States
- Currency
- USD
- Country
- United States
Financial Metrics
- Revenue (TTM)
- $5.24B
- EBITDA
- $1.13B
- Profit Margin
- 11.70%
- EPS (TTM)
- 2.59
- Book Value
- 34.74
Technical Indicators
- 52 Week High
- $213.50
- 52 Week Low
- $107.92
- 50 Day MA
- $194.26
- 200 Day MA
- $181.32
- Beta
- -0.10
Valuation
- Trailing P/E
- 79.96
- Forward P/E
- 46.51
- Price/Sales
- 9.29
- Price/Book
- 5.96
- Enterprise Value
- $49.36B